Eyewire News

Featured Story

Kodiak Reports Phase 3 DAYBREAK Trial Meets Primary Endpoints for Zenkuda in Wet AMD image

09.28.2026

Kodiak Reports Phase 3 DAYBREAK Trial Meets Primary Endpoints for Zenkuda in Wet AMD

Kodiak Sciences announced positive topline results from the phase 3 DAYBREAK study, reporting that both Zenkuda (tarcocimab tedromer) and tabirafusp-ted (KSI-501) met the trial's primary endpoints in patients with wet age-related macular degeneration (AMD). According to the company, both investigational therapies achieved noninferiority to aflibercept for vision gains at 1 year.

Read Story

Latest News Stories

Alcon to Present Dry Eye, Contact Lens Research and Technology Experiences at AAOpt image

09.29.2026

Alcon to Present Dry Eye, Contact Lens Research and Technology Experiences at AAOpt

09.29.2026

Tarsus to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of Xdemvy at AAOpt

Johnson & Johnson Data Highlight Moisture Retention Differences Among Daily Disposable Contact Lenses image

09.29.2026

Johnson & Johnson Data Highlight Moisture Retention Differences Among Daily Disposable Contact Lenses

09.29.2026

CooperVision Research Identifies Opportunities for Earlier Multifocal Contact Lens Conversations

MyEyeDr. to Acquire EyeCare Partners Optometry Division, Adding More than 300 Offices image

09.29.2026

MyEyeDr. to Acquire EyeCare Partners Optometry Division, Adding More than 300 Offices

Aldeyra Plans to Appeal FDA Rejection of Reproxalap NDA image

09.29.2026

Aldeyra Plans to Appeal FDA Rejection of Reproxalap NDA

Contact Lens Institute Report Finds Higher Practice Profitability Associated with Contact Lens Patients image

09.29.2026

Contact Lens Institute Report Finds Higher Practice Profitability Associated with Contact Lens Patients

4D Molecular Therapeutics Enrolls First Patients in Phase 3 4SIGHT Trial of 4D-150 for DME image

09.28.2026

4D Molecular Therapeutics Enrolls First Patients in Phase 3 4SIGHT Trial of 4D-150 for DME

09.28.2026

International Study Shows Deep Learning Model Predicting Glaucoma Progression Years Ahead From a Single Fundus Photograph

09.28.2026

Medevise Consulting to Host “Robotics in Ophthalmology” Workshop During AAO

European Commission Approves Roche's Susvimo for Wet AMD image

09.25.2026

European Commission Approves Roche's Susvimo for Wet AMD

09.25.2026

UK Study: Novai’s DARC Imaging Shows Promise for Predicting Macular Atrophy Progression in AMD

Glaucoma Vision Act of 2026 Seeks to Expand Screening Access, Fund Research image

09.25.2026

Glaucoma Vision Act of 2026 Seeks to Expand Screening Access, Fund Research

09.25.2026

Claris Biotherapeutics Relocates Headquarters to San Francisco

Annexon to Present Vonaprument Geographic Atrophy Data at Retina Society Meeting image

09.25.2026

Annexon to Present Vonaprument Geographic Atrophy Data at Retina Society Meeting

09.24.2026

FDA Advisory Committee to Review Sydnexis’ SYD-101 for Pediatric Progressive Myopia

FDA Approves Rayner’s RayOne Galaxy Spiral IOL Platform image

09.24.2026

FDA Approves Rayner’s RayOne Galaxy Spiral IOL Platform

09.24.2026

Merck Reports Remigromig Meets Primary Endpoint in Phase 2b/3 BRUNELLO Trial for Diabetic Macular Edema

Zeiss Expands Retina Workflow with New Imaging, Visualization and Vitrectomy technologies image

09.24.2026

Zeiss Expands Retina Workflow with New Imaging, Visualization and Vitrectomy Technologies

View More